Median effective infusion rate (ED50) of continuous cisatracurium for preserving interpretable TceMEP signals during intraspinal tumor resection: a prospective up-and-down sequential allocation study. [PDF]
Yan S, Guo M, Wen X, He Z.
europepmc +1 more source
Perioperative Anaphylactic Shock Induced by Cisatracurium: A Case Demonstrating the Diagnostic and Clinical Value of Early Skin Testing. [PDF]
Ying Y, Tian S, Chen J, Wang K, Li S.
europepmc +1 more source
Low-Dose Intravenous Challenge Testing to Neuromuscular Blocking Agents: A Safe and Effective Approach to the Investigation of Perioperative Anaphylaxis. Comment on Clin Exp Allergy 2026;56:438-441. [PDF]
Misbah SA, Pollard RC.
europepmc +1 more source
Evaluation of the effects of a single bolus of cisatracurium as part of an anesthetic protocol in cats undergoing orthopedic surgery. [PDF]
Interlandi C +7 more
europepmc +1 more source
Effect of Adjunctive Train-of-Four Monitoring Using Peripheral Nerve Stimulation on Neuromuscular Blocking Agent Dose in PICU Patients: A Randomized Crossover Study. [PDF]
Limprayoon K +5 more
europepmc +1 more source
Lumbar microdiscectomy during first trimester of pregnancy: Surgical, anesthetic, and radiation considerations with review of reported cases. [PDF]
Ismail Z +3 more
europepmc +1 more source
Comparative efficacy and safety of multiple acupoint electrical stimulation therapies for postoperative cognitive dysfunction in cancer patients: a network meta-analysis. [PDF]
Chen Z +7 more
europepmc +1 more source
Dexmedetomidine as an Adjunct to Transversus Abdominis Plane Block in Patients Undergoing Cancer Surgeries: A Systematic Review and Meta-Analysis. [PDF]
Alotaibi RA +13 more
europepmc +1 more source
Importance of the early recognition, early suspicion, and early treatment for malignant hyperthermia crisis: two case reports. [PDF]
Hu C, Song W, Lin H, Wu Y, Fu G, Lin D.
europepmc +1 more source
Myxomatous Mitral Valve Disease and CHARGE Syndrome: An Uncommon Association. [PDF]
Mukati R, Singh A, Mehta Y.
europepmc +1 more source

